Strength
180 mg/1
Manufacturer
Esperion Therapeutics, Inc.NDC
72426011803
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
BEMPEDOIC ACIDApproval Type
New Drug (NDA)
FDA Application
NDA211616On Market Since
3/6/2020
Pharmacological Classes
Adenosine Triphosphate-Citrate Lyase Inhibitor
Adenosine Triphosphate-Citrate Lyase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification